Harris & Harris : Ensemble Announces Global Pharma Partner Expansion
May 25, 2016 at 10:51 am EDT
Share
May 25, 2016
Shareholders of Harris & Harris Group, Inc. may be interested to read the recent release by Ensemble on the expansion of their partnership with Novartis: ENSEMBLE IL-17. Ensemble Therapeutics is a Harris & Harris Group portfolio company.
Detailed information about Harris & Harris Group, Inc., and its holdings can be found on its website at www.HHVC.com, on Facebook at www.Facebook.com/harrisharrisvc and by following us on Twitter @harrisandharrisgroup. This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references to the websites www.HHVC.com, www.prnewswire.com and www.Facebook.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.
Close window | Back to top
Harris & Harris Group Inc. published this content on 25 May 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 May 2016 14:50:05 UTC.
Original documenthttp://ir.hhvc.com/releasedetail.cfm?ReleaseID=972815
Public permalinkhttp://www.publicnow.com/view/1F2CAC0C2B63450E375B9DB3063527DFCD384579
180 Degree Capital Corp. is a non-diversified closed-end management investment company. The Company operates as an internally managed investment company. The Companyâs investment objective is to generate capital appreciation and current income from investments and investment-related activities such as managed funds and accounts. The Company invests its assets in various industries, including advertising, application software, asset management and custody banks, biotechnology, communications equipment, construction machinery and heavy trucks, electronic manufacturing services, fertilizers and agricultural chemicals, health care equipment, health care technology, interactive media and services, pharmaceuticals, restaurants, specialized finance, specialty chemicals, technology hardware, storage and peripherals, trading companies and distributors, miscellaneous common stocks industries, steel and apparel, accessories and luxury goods.
HARRIS & HARRIS GROUP, INC. 
